AHF Opposes Creation of Splinter 340B Drug Discount Program
AIDS Healthcare Foundation ( AHF ) opposes the creation of a new drug discount program, 340C, for non-hospital community health providers.
- AIDS Healthcare Foundation ( AHF ) opposes the creation of a new drug discount program, 340C, for non-hospital community health providers.
- The push for the new federal program stems from unlawful efforts of drug companies to disable an already existing program, the 340B Drug Pricing Program , which has protected public health for 30 years.
- Instead of aiding drug company priorities, 340B entities - which comprise the public health safety net in this country - must continue to work together to strengthen and protect the 340B program.
- AHF urges 340B providers not to fall for the drug industrys divide-and-conquer trap, said Tom Myers, AHF General Counsel.